- Home
- ABT vs SHEL Comparison
ABT vs SHEL Comparison
Compare ABT & SHEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABT
- SHEL
- Stock Information
- Founded
- ABT 1888
- SHEL 1907
- Country
- ABT United States
- SHEL United Kingdom
- Employees
- ABT N/A
- SHEL N/A
- Industry
- ABT Medical/Dental Instruments
- SHEL Oil & Gas Production
- Sector
- ABT Health Care
- SHEL Energy
- Exchange
- ABT Nasdaq
- SHEL Nasdaq
- Market Cap
- ABT 221.0B
- SHEL N/A
- IPO Year
- ABT N/A
- SHEL N/A
- Fundamental
- Price
- ABT $132.64
- SHEL $73.28
- Analyst Decision
- ABT Buy
- SHEL Strong Buy
- Analyst Count
- ABT 18
- SHEL 7
- Target Price
- ABT $136.06
- SHEL $79.97
- AVG Volume (30 Days)
- ABT 7.4M
- SHEL 5.8M
- Earning Date
- ABT 04-16-2025
- SHEL 05-02-2025
- Dividend Yield
- ABT 1.78%
- SHEL 3.91%
- EPS Growth
- ABT 134.36
- SHEL N/A
- EPS
- ABT 7.64
- SHEL 2.53
- Revenue
- ABT $41,950,000,000.00
- SHEL $284,312,000,000.00
- Revenue This Year
- ABT $6.72
- SHEL $4.55
- Revenue Next Year
- ABT $7.45
- SHEL N/A
- P/E Ratio
- ABT $17.36
- SHEL $28.96
- Revenue Growth
- ABT 4.59
- SHEL N/A
- 52 Week Low
- ABT $99.71
- SHEL $60.15
- 52 Week High
- ABT $141.23
- SHEL $74.61
- Technical
- Relative Strength Index (RSI)
- ABT 56.61
- SHEL 73.32
- Support Level
- ABT $124.50
- SHEL $70.77
- Resistance Level
- ABT $133.46
- SHEL $74.18
- Average True Range (ATR)
- ABT 2.67
- SHEL 0.94
- MACD
- ABT 0.11
- SHEL 0.31
- Stochastic Oscillator
- ABT 90.85
- SHEL 88.66
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.